by TractManager | Dec 21, 2020 | Molecular Test Assessment
The report evaluates the analytical validity, clinical validity, and clinical utility of the VeriStrat test, a liquid biopsy-based proteomic test that identifies a chronic inflammatory immune response indicative of aggressive disease in patients with advanced...
by TractManager | Dec 17, 2020 | Health Technology Assessment
Focus of the Report: This report focuses on the efficacy and safety of the calcitonin gene-related peptide (CGRP) receptor antagonist ubrogepant (Ubrelvy) for acute treatment of migraines.Technology Description: Ubrogepant is approved for the acute treatment of...
by TractManager | Dec 15, 2020 | News
The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) has issued an interim recommendation for use of the Pfizer-BioNTech COVID-19 vaccine.On December 11, 2020, the Food and Drug Administration (FDA) issued an...
by TractManager | Dec 11, 2020 | Health Technology Assessment
Focus of the Report: This report focuses on fractional flow reserve (FFR), determined noninvasively via computed tomography (FFRCT), to detect coronary artery blockages, identified by coronary computed tomography angiography (CCTA), that may be responsible for...
by TractManager | Dec 11, 2020 | Health Technology Assessment
Focus of the Report: This report evaluates the use of axicabtagene ciloleucel (Yescarta) for the treatment of relapsed or refractory (r/r) large B-cell lymphoma (LBCL).Technology Description: Axicabtagene ciloleucel therapy is a form of chimeric antigen receptor (CAR)...
Recent Comments